PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Tilray Brands, Inc. (TLRY.TO)
2.000.05 (2.56%)
1.90 - 2.15
0.48 - 2.54
9.88M / 3.06M (Avg.)
-0.59 | -3.40
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
-12.98%
Revenue decline while CRON.TO shows 6.47% growth. Joel Greenblatt would examine competitive position erosion.
-15.76%
Both companies reducing costs. Martin Whitman would check industry efficiency trends.
-5.67%
Gross profit decline while CRON.TO shows 27.08% growth. Joel Greenblatt would examine competitive position.
8.39%
Margin expansion below 50% of CRON.TO's 19.36%. Michael Burry would check for structural issues.
-73.35%
Both companies reducing R&D. Martin Whitman would check industry innovation trends.
-7.64%
Both companies reducing G&A. Martin Whitman would check industry cost trends.
-9.84%
Both companies reducing marketing spend. Martin Whitman would check industry trends.
154.29%
Other expenses growth 1.1-1.25x CRON.TO's 126.51%. Bill Ackman would demand expense justification.
14.76%
Operating expenses growth while CRON.TO reduces costs. John Neff would investigate differences.
-5.54%
Both companies reducing total costs. Martin Whitman would check industry trends.
-55.84%
Interest expense reduction while CRON.TO shows 0.00% growth. Joel Greenblatt would examine advantage.
0.26%
D&A growth less than half of CRON.TO's 12.48%. David Dodd would verify if efficiency is sustainable.
-28.36%
EBITDA decline while CRON.TO shows 92.34% growth. Joel Greenblatt would examine position.
-18.55%
EBITDA margin decline while CRON.TO shows 92.81% growth. Joel Greenblatt would examine position.
-77.54%
Operating income decline while CRON.TO shows 64.17% growth. Joel Greenblatt would examine position.
-104.02%
Operating margin decline while CRON.TO shows 66.35% growth. Joel Greenblatt would examine position.
113.69%
Other expenses growth while CRON.TO reduces costs. John Neff would investigate differences.
21.48%
Pre-tax income growth while CRON.TO declines. John Neff would investigate advantages.
9.77%
Pre-tax margin growth while CRON.TO declines. John Neff would investigate advantages.
103.21%
Tax expense growth while CRON.TO reduces burden. John Neff would investigate differences.
-23.37%
Both companies show declining income. Martin Whitman would check industry conditions.
-41.77%
Both companies show margin pressure. Martin Whitman would check industry conditions.
-11.75%
Both companies show declining EPS. Martin Whitman would check industry conditions.
-11.75%
Both companies show declining diluted EPS. Martin Whitman would check industry conditions.
10.30%
Share count increase while CRON.TO reduces shares. John Neff would investigate differences.
10.30%
Diluted share increase while CRON.TO reduces shares. John Neff would investigate differences.